PRIN SIDERALE: Susceptibility to Infectious Diseases in obEsity: an endocRine trAnslational socioLogic Evaluation

Status: Recruiting
Location: See all (4) locations...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Obesity is a life-threatening disease, defined by excessive fat accumulation that increases the risk of other diseases such as cardiovascular events, hypertension, diabetes and cancer. Obesity is also a risk factor for nosocomial infections and is associated with worse COVID-19 outcomes, although anthropometric measurements are not routinely recorded during hospitalization and lack of a registry data does not allow performing retrospective studies.Obesity is closely related to chronodisruption, characterized by deregulation of physiological and behavioral central and peripheral circadian rhythms contributing to the obesity-related metabolic impairment. Eating and sleeping time schedules are relevant synchronizers of humans' biological clock. Several studies suggest a role of dietary interventions in rewiring the circadian rhythm, with Mediterranean diet (MD) regulating nutritional patterns. Moreover, considering its positive impact on sleep quality, melatonin intake was suggested as a potential regulator of circadian rhythms. The relation between chronodisruption, obesity and infections has not been investigated, and a first proof of concept (Pilot study) will aim at investigating it. Three cohorts of obese patients with different aetiology (essential obesity, obesity with type 2 diabetes, genetic forms of obesity) and a cohort of lipodystrophic patients will be enrolled in the study, which is designed as a two-phases protocol. During the first phase (0-12 weeks (w)) patients will be subjected to dietary intervention with hypocaloric MD; in a second phase (12-24w), melatonin 1mg/die before sleep will be added to the hypocaloric MD. The susceptibility to infections will be investigated through the evaluation of 1) the number of events - i.e. flu- or flulike syndromes, skin, respiratory, digestive, urinary infections-per patient of the 4 groups and the blood assays to detect the infection with Epstein-Barr, Cytomegalovirus, Varicella, Measles and SARS-CoV-2 IgG and IgM; hepatitis C and hepatitis B core antibodies and Quantiferon TB Gold, 2) the clock genes rhythm and TLRs expression in patient immune cells at baseline, 12w and 24w.The mutual relationship between biomedical values, environmental and social conditions, and lifestyle habits will be evaluated by structured questionnaires. Validation of questionnaires to explore the susceptibility to infections is another delivery planned for the current study.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:

• essential obesity (BMI : 30-35 Kg/m2)

• genetic forms of obesity (BMI: 30-35 Kg/m2)

• obesity (BMI:30-35 Kg/m2) associated with T2DM

• obesity (BMI:30-35 Kg/m2) associated with endocrinopathies

• lipodystrophy

Locations
Other Locations
Italy
Federico II University of Naples, Department of Clinical and Molecular Endocrinology and Oncology
RECRUITING
Naples
Università del Piemonte Orientale
RECRUITING
Novara
University of Pisa
RECRUITING
Pisa
Sapienza University of Rome
RECRUITING
Roma
Contact Information
Primary
Annamaria Colao, Prof
colao@unina.it
+393285390000
Time Frame
Start Date: 2023-12-29
Estimated Completion Date: 2026-10-29
Participants
Target number of participants: 100
Treatments
Active_comparator: Mediterranean diet group
At baseline (T0), all patients will be subjected to anthropometric determinations, including body weight and height for BMI calculation, body composition by mean of DXA Scan, blood, serum and urine collection, oral cavity swab and stool sampling. Patients will undergo a session of behavioural dietary counselling by which patients will be educated to adhere to a hypocaloric MD for the first 12w (T1).
Active_comparator: Mediterranean diet plus melatonin group
After the first 12 w of the study (T2), all patients will continue a hypocaloric MD adding the supplementation with 1mg/die of melatonin before bedtime for other 12w.
Sponsors
Leads: Federico II University
Collaborators: Università degli Studi del Piemonte Orientale Amedeo Avogadro, University of Pisa, University of Roma La Sapienza, University of Rome Foro Italico

This content was sourced from clinicaltrials.gov